Results 171 to 180 of about 16,645 (269)

Has the Safety of Edoxaban 60 mg Among East Asian Atrial Fibrillation Patients Been Truly Proven by the ENGAGE AF-TIMI 48 Subanalysis?

, 2016
Tomiya Yasumasu
openalex   +2 more sources

Assess the reporting quality of randomized controlled trials exploring the efficacy and safety of the new anticoagulants versus warfarin in patients with atrial fibrillation, based on CONSORT statement [PDF]

, 2015
Καράκου, Ευγενία Δ.
core   +1 more source

Comparison of Once-Daily Administration of Edoxaban and Rivaroxaban in Asian Patients with Atrial Fibrillation [PDF]

, 2019
So‐Ryoung Lee, Eue‐Keun Choi, Kyungdo Han, Jin‐Hyung Jung, Seil Oh, Gregory Y.H. Lip   +5 more
openalex   +1 more source

Rapid Screening of Anticoagulation Compounds for Biological Target-Associated Adverse Effects Using a Deep-Learning Framework in the Management of Atrial Fibrillation. [PDF]

Bioengineering (Basel)
Dong T, Llewellyn R, Hezzell M, Angelini GD.   +3 more
europepmc   +1 more source

Efficacy and safety of edoxaban for treatment of portal vein thrombosis following danaparoid sodium in patients with liver cirrhosis

, 2017
Yuko Nagaoki, Hiroshi Aikata, Kana Daijyo, Yuji Teraoka, Fumi Shinohara, Yuki Nakamura, Masahiro Hatooka, Kei Morio, Takashi Nakahara, Tomokazu Kawaoka, Masataka Tsuge, Akira Hiramatsu, Michio Imamura, Yoshiiku Kawakami, Hidenori Ochi, Kazuaki Chayama   +15 more
openalex   +1 more source

Venous Thromboembolism Therapy with Edoxaban in Daily Care Patients: Results from the DRESDEN NOAC REGISTRY. [PDF]

TH Open
Tittl L, Köhler C, Marten S, Naue C, Beyer-Westendorf J.   +4 more
europepmc   +1 more source

Evaluation of the safety and efficacy of an edoxaban-based antithrombotic regimen in patients with atrial fibrillation following successful percutaneous coronary intervention (PCI) with stent placement: Rationale and design of the ENTRUST-AF PCI trial

, 2017
Pascal Vranckx, Thorsten Lewalter, Marco Valgimigli, Jan G.P. Tijssen, Paul‐Egbert Reimitz, Lars Eckardt, Hans‐Joachim Lanz, Wolfgang Zierhut, Rüdiger Smolnik, Andreas Goette   +9 more
openalex   +1 more source

Association Between Direct Oral Anticoagulants and Wunderlich Syndrome: A Case Report and a Comprehensive Analysis of the Literature and Evidence. [PDF]

Cureus
Khan A, Chuang YA, Gkentzis A, Harvey N.
europepmc   +1 more source

Superior mesenteric vein thrombosis treated with edoxaban [PDF]

Journal of General and Family Medicine, 2017
Takanori Nomura, Makoto Kondo, Satoshi Suzuki, Yutaka Hashizume   +3 more
openaire   +3 more sources

Hemorrhage Risk Associated with Anticoagulant and Antiplatelet Drug Combinations: Insights from the USFDA Adverse Event Reporting System. [PDF]

J Clin Med
Sridharan K, Sivaramakrishnan G.
europepmc   +1 more source